Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponesimod vs Teriflunomide in Relapsing Multiple Sclerosis
NCT02425644Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jun 2015
- Primary completion
- May 2019
- Modality
- Covalent Small Molecules, Molecular Glues, Classical Binding Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of ponesimod in multiple sclerosis (MS), sponsored by Actelion Pharmaceuticals Ltd. Started Jun 2015; status: completed.
02
Drugs
ponesimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02425644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02425644.